Breast cancer: from “maximum tolerable” to “minimum effective” treatment
Randomized trials have played a fundamental role in identifying better treatments for most type of diseases, especially in the oncological field. In breast cancer, the shift from “maximum tolerable” to “minimum effective” treatment has been evident since the 1970s and has been based on the results o...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Frontiers Media S.A.
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465814/ |